Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference78 articles.
1. Head and neck cancer: past, present and future
2. Malignancies of the head and neck: the role for molecular targeted agents
3. Cancer Statistics, 2007
4. End points for new agents in induction chemotherapy for locally advanced head and neck cancers
5. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral Mucositis;Orofacial Supportive Care in Cancer;2022
2. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models;Lung Cancer;2016-05
3. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization;Molecular Biology Reports;2013-05-08
4. Oral complications of targeted cancer therapies: A narrative literature review;Oral Oncology;2011-06
5. The Role of Targeted Molecular Inhibitors in the Management of Advanced Nonmelanoma Skin Cancer;Seminars in Cutaneous Medicine and Surgery;2011-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3